Prehabilitation for people with prostate cancer
Official title: Prehabilitation to Patients With Prostate Cancer, Who Are About to Receive Androgen Deprivation Therapy and Radiation Therapy
Run by Odense University Hospital · NCT07162987 · Data updated 2026-11-12
This project will test a 12-week multicomponent prehabilitation program, including a 4-day residential course and supervised exercise, to see if it helps men with prostate cancer starting androgen deprivation plus radiation therapy better tolerate treatment side-effects.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Men only |
| Enrollment | 20 (estimated) |
| Sponsor | Odense University Hospital Academic / other |
| Locations | 3 sites (Esbjerg, Region Syddanmark and 2 other locations) |
| Status | Recruiting |
| Started | August 4, 2025 |
| Main results expected | November 2026 |
| Study ends | November 2026 |
| Registry record updated | September 9, 2025 |
| Trial ID | NCT07162987 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults diagnosed with prostate cancer who are scheduled for androgen deprivation therapy plus radiation, live in Vejle or Esbjerg Municipality, can attend the residential prehabilitation in week 43 or 50 of 2025, speak and read Danish, and can participate in group-based exercise and education sessions.
✕Probably not a fit
Patients who cannot travel to the residential stay, cannot participate in group sessions, do not speak Danish, have limiting comorbidities that prevent exercise, or are not receiving the specified ADT plus radiation treatment are unlikely to benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a feasibility study of a newly developed multicomponent prehabilitation program for patients with prostate cancer who will receive androgen deprivation therapy and radiation. Participants take part in 12 weeks of physical exercise training and attend a 4-day residential prehabilitation course that includes education and practical exercises, with an optional follow-up session. The study will collect questionnaires from patients and close relatives and gather feedback from healthcare professionals to determine acceptability and feasibility. The investigators will also look for indications of clinical effect and whether the planned data collection methods work in this setting.
Why it matters
Potential benefit: If successful, the program could help patients better withstand treatment side-effects and maintain quality of life during and after therapy.
How similar studies have gone: Prehabilitation interventions have shown promise in improving resilience and recovery in other cancer and surgical populations, but multicomponent residential prehabilitation specifically for prostate cancer patients receiving ADT and radiation remains relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosed with prostate cancer * min 18 years old * Treatment: Androgen deprivation therapy and raditation therapy * Resident in Vejle Municipality or Esbjerg Municipality * Can take part in residential prehabiliation in week 43 or 50, 2025, as well as physical exsercise training in the municipality * Willing to take part in a research study * Suited to take part in group sessions * Be able to read and be understood in Danish * Be responsible for own personal hygiene and medications at the 4-day residential stay Exclusion Criteria: * Persons who do not fulfil the inclusion criteria will be excluded
Where it's running
-
Esbjerg Hospital
Esbjerg, Region Syddanmark, Denmark Recruiting -
REHPA, the Danish Knowledge Centre for Rehabilitation and Palliative Care
Nyborg, Region Syddanmark, Denmark Recruiting -
Vejle Hospital
Vejle, Region Syddanmark, Denmark Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
68Ga-XMFH01 PET/FL imaging to guide prostate cancer surgery
This study tests a new dual-modality imaging probe, 68Ga-XMFH01, to preoperatively detect prostate cancer and guide the surgeon with fluorescence during operations in adults with newly diagnosed prostate cancer.
-
Hugo Robotic Prostatectomy in an Ambulatory Surgery Center
This study tests the use of the Hugo robotic system for prostate removal in adult men treated at an outpatient surgical center.
-
Adaptive intraoperative biopsy system for prostate cancer using imaging and metabolic feedback
Aiming to test a smart biopsy approach that combines preoperative imaging with real-time metabolic signals to guide where to take prostate biopsy cores for better precision in men suspected of prostate cancer.
-
miRNA panel test to help diagnose prostate cancer
A blood test using a microRNA panel is being tested to help diagnose prostate cancer in men who are suspected of having the disease.
-
Testing 68Ga-NYM032 PET/CT in men with newly diagnosed prostate cancer
This study tests a new PSMA-targeted PET/CT imaging agent to see if it safely and accurately locates cancer in men who have just been diagnosed with prostate cancer and are planned for surgery.
-
Multi-Modal Imaging and Digital Pathology to Predict Clinically Significant Prostate Cancer
A multi-center study tests a deep learning model that combines MRI, ultrasound, and digital pathology to see if it can predict clinically significant prostate cancer non-invasively and help guide biopsies.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.